Waldenström macroglobulinemia (WM) is a rare form of blood cancer.

Sixth symposium on WM

Written by Joanna, published 6 months ago.

2011, November 19
UZ Brussels
 

In the capital of Europe nearly 40 interested people come together to attend the sixth symposium on WM: patients, partners, caregivers. Dr. Fabienne Trullemans, connected to above mentioned hospital as a hematologist, starts with a very clear exposition of WM, the signs and symptoms, diagnosis and treatment. Newly diagnosed are reassured. All patients receive information about the current therapeutic arsenal available to treat the disease.
After lunch the audience can hear a very interesting presentation from a lawyer working at the research department of the Flemish League against Cancer: ‘The cost of care for hematologic disease for the patient’.
Satisfied and with positive feelings everyone goes home, ready to be back next year for the seventh symposium.

Written by Joanna, published 6 months ago.

No comment for «Sixth symposium on WM»

Expand all ]

No comment yet.

Leave a comment

You must be registered and signed in to leave a comment. Sign in now.

Waldenstrom macroglobulinemia Recent Activity

  • -

    waldenstrom
    topic, published about 10 hours ago

    show transcript

    i'm a 61 years old Waldenstrompatient from Belgium, i has been for 6 mouths under chemo, my uncologe Nathalie Van Heddeghem at the Academisch Ziekenhuis in geraardsbergen
    oost-Vlaanderen Belgium follo
    wt the methode off the Majoclinique whith Mabtera
    My situation before: igM value was 2800
    n...

  • -

    Six years with MGUS-IgMK
    topic, published about 10 hours ago

    show transcript

    I am 67 years old. In 2006, following a routine check-up, my gamma globulins percentage was 19.4, which was over the maximum of the reference values. At my following check-up the value increased so I consulted a haematologist who diagnosed a MGUS-IgMK and prescribed a blood test every six months ...

  • -

    newcomer
    topic, published 1 day ago

    show transcript

    Hello everybody, I hope I can find there the information I've been searching since 2009 because like many patients, doctors haven't told me much and all I know about MW I found it on the web

  • -

    Herpes zoster/Shingles
    topic, published 19 days ago

    show transcript

    I would like to hear your opinion on a recurring problem I have been suffering from recently...I have had to undergo several cycles for treating herpes zoster on one of my arms...it is as if my system cannot overcome infections...in addition my electrophoresis just changes suddenly, even each ...

  • -

    EWM NETWORK NEWSLETTER MARCH 2012
    document, published about 1 month ago

    show transcript

  • -

    EWM Network Annual Report 2011
    document, published about 1 month ago

    show transcript

  • -

    3rd International WM Patient Forum - latest news
    topic, published 2 months ago

    show transcript

    Hello all

    WMUK is a charitable partnership between people WM patients, carers, specialist doctors and nurses. It aims to bring them closer together and to lobby for the latest and best treatments. Although UK based, it also welcomes Irish patients, carers and doctors.

    WMUK hosted the 3rd In...

  • -

    start of therapy
    topic, published 2 months ago

    show transcript

    Beginning of therapy

    Chemo
    27/2 antinausea + bendamustine
    28/2 antinausea + bendamustine
    I reacted pretty well, I got a little sick, only the first 2/3 days but it was bearable, nothing serious.
    Anticlonale
    05/03 I took the Rituxan. I started at 09.30. Aspirin + a dose of 100ml with infus...

  • -

    Holistics
    topic, published 2 months ago

    show transcript

    Is there anyone else in this community that has tried or uses B17?

  • -

    Interesting article on the future of cancer research and treatment
    topic, published 2 months ago

    show transcript

    Dear all
    You may find the following interesting:
    http://io9.com/5883180/why-havent-we-cured-cancer-yet
    The article makes the point (among many others) that targeted treatments are emerging particularly in small disease groups. It looks like those of us who have rare diseases have something to ...